Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

RSLS

ReShape Lifesciences Inc.

Healthcare

Set alert

Price alert · RSLS

All alert types
3.92 0.00 0.00%
As of Aug 14, 2025
2.80 Day range 4.65
4.09 52-week range 29.00
YTD
-99.12%
1 year
-99.62%
Open
3.06
Prev close
3.92
Mkt cap
3.04M
Vol
13.59M
Avg vol
113.58K
EPS
77.26
P/E
0.06
Div yield
0.00%
More statistics
Low
2.80
High
4.65
Forward P/E
-11.83
Beta
1.35
Short ratio
0.22
Inst. own
1.83%
Dividend
0.00
Ex-div date
50-d avg
5.39
200-d avg
9.00
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for RSLS has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-12.12 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -3.3×
FY 2016: -7.3×FY 2017: -12.7×FY 2018: -4.2×FY 2019: -1.5×FY 2020: -2.6×FY 2021: -1.1×FY 2022: -0.2×FY 2023: -0.5×FY 2024: -1.3×FY 2025: -3.3×
FY 2016 5y median -1.1× FY 2025
P/S 106×
FY 2016: 0.0×FY 2017: 343×FY 2018: 260×FY 2019: 2.4×FY 2020: 5.0×FY 2021: 5.3×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 1.1×FY 2025: 106×
FY 2016 5y median 1.1× FY 2025
P/B 9.0×
FY 2016: 0.0×FY 2017: 5.8×FY 2018: 5.0×FY 2019: 1.5×FY 2020: 3.9×FY 2021: 1.6×FY 2022: 3.1×FY 2023: 0.9×FY 2024: -36.4×FY 2025: 9.0×
FY 2016 5y median 1.6× FY 2025
P/FCF -9.0×
FY 2016: 0.0×FY 2017: -17.9×FY 2018: -5.7×FY 2019: -2.6×FY 2020: -6.3×FY 2021: -4.6×FY 2022: -0.5×FY 2023: -0.3×FY 2024: -2.1×FY 2025: -9.0×
FY 2016 5y median -2.1× FY 2025
EV/EBITDA -10.6×
FY 2016: 0.2×FY 2017: -13.3×FY 2018: -4.3×FY 2019: -1.6×FY 2020: -3.7×FY 2021: -0.8×FY 2022: -0.3×FY 2023: -0.1×FY 2024: -1.4×FY 2025: -10.6×
FY 2016 5y median -0.8× FY 2025
EV/Sales 90.5×
FY 2016: -4.0×FY 2017: 336×FY 2018: 261×FY 2019: 2.3×FY 2020: 5.9×FY 2021: 3.6×FY 2022: 0.7×FY 2023: 0.2×FY 2024: 1.2×FY 2025: 90.5×
FY 2016 5y median 1.2× FY 2025
FCF Yield -11.1%
FY 2016: 0.0%FY 2017: -5.6%FY 2018: -17.5%FY 2019: -39.1%FY 2020: -15.9%FY 2021: -21.9%FY 2022: -192.4%FY 2023: -285.9%FY 2024: -48.1%FY 2025: -11.1%
FY 2016 5y median -48.1% FY 2025

Profitability

Gross Margin 68.4%
FY 2016: 45.2%FY 2017: 27.3%FY 2018: 72.9%FY 2019: 61.7%FY 2020: 55.4%FY 2021: 61.4%FY 2022: 60.5%FY 2023: 63.9%FY 2024: 63.2%FY 2025: 68.4%
FY 2016 5y median 63.2% FY 2025
Operating Margin -859.2%
FY 2016: -2897.8%FY 2017: -2440.1%FY 2018: -6353.3%FY 2019: -105.3%FY 2020: -110.2%FY 2021: -183.3%FY 2022: -240.9%FY 2023: -177.3%FY 2024: -96.5%FY 2025: -859.2%
FY 2016 5y median -183.3% FY 2025
Net Margin -3209.7%
FY 2016: -2969.6%FY 2017: -2627.3%FY 2018: -13375.7%FY 2019: -491.8%FY 2020: -191.4%FY 2021: -464.3%FY 2022: -411.2%FY 2023: -131.2%FY 2024: -89.1%FY 2025: -3209.7%
FY 2016 5y median -411.2% FY 2025
ROE -272.8%
FY 2016: -794.9%FY 2017: -44.3%FY 2018: -256.3%FY 2019: -307.8%FY 2020: -149.3%FY 2021: -142.4%FY 2022: -1262.3%FY 2023: -170.9%FY 2024: 2818.2%FY 2025: -272.8%
FY 2016 5y median -170.9% FY 2025
ROIC -72.4%
FY 2016: -397.9%FY 2017: -32.8%FY 2018: -73.4%FY 2019: -53.1%FY 2020: -42.0%FY 2021: -54.8%FY 2022: -700.9%FY 2023: -219.9%FY 2024: -1052.9%FY 2025: -72.4%
FY 2016 5y median -219.9% FY 2025
ROA -157.9%
FY 2016: -331.8%FY 2017: -38.1%FY 2018: -175.4%FY 2019: -187.1%FY 2020: -58.4%FY 2021: -120.2%FY 2022: -414.8%FY 2023: -106.8%FY 2024: -148.8%FY 2025: -157.9%
FY 2016 5y median -148.8% FY 2025

Growth (YoY)

Revenue -96.0%
FY 2016: 169.4%FY 2017: 63.6%FY 2018: -52.9%FY 2019: 2387.0%FY 2020: -25.1%FY 2021: 20.4%FY 2022: -17.4%FY 2023: -22.8%FY 2024: -7.7%FY 2025: -96.0%
FY 2016 FY 2025
Operating Income 64.5%
FY 2016: 18.2%FY 2017: -37.8%FY 2018: -22.7%FY 2019: 58.8%FY 2020: 21.6%FY 2021: -100.2%FY 2022: -8.6%FY 2023: 43.2%FY 2024: 49.8%FY 2025: 64.5%
FY 2016 FY 2025
EPS (diluted) 98.6%
FY 2016: -420.7%FY 2017: 57.1%FY 2018: 5.6%FY 2019: 74.4%FY 2020: 54.0%FY 2021: 16.7%FY 2022: 62.3%FY 2023: 98.2%FY 2024: 87.5%FY 2025: 98.6%
FY 2016 FY 2025
Free Cash Flow 15.3%
FY 2016: 8.7%FY 2017: -19.6%FY 2018: -11.4%FY 2019: 48.4%FY 2020: 37.1%FY 2021: -75.9%FY 2022: -40.1%FY 2023: 22.8%FY 2024: 74.0%FY 2025: 15.3%
FY 2016 FY 2025

Financial Health

Current Ratio 2.0×
FY 2016: 4.4×FY 2017: 12.8×FY 2018: 1.0×FY 2019: 1.0×FY 2020: 0.8×FY 2021: 4.0×FY 2022: 1.3×FY 2023: 2.7×FY 2024: 0.9×FY 2025: 2.0×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 2.0×
FY 2016: 3.0×FY 2017: 10.2×FY 2018: 0.9×FY 2019: 0.8×FY 2020: 0.6×FY 2021: 3.6×FY 2022: 0.8×FY 2023: 1.7×FY 2024: 0.4×FY 2025: 2.0×
FY 2016 5y median 1.7× FY 2025
Debt / Equity 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.2×FY 2019: 0.0×FY 2020: 0.9×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -3.8×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 1.8×
FY 2016: 0.2×FY 2017: 0.3×FY 2018: -0.0×FY 2019: 0.1×FY 2020: -0.6×FY 2021: 0.4×FY 2022: 0.1×FY 2023: 0.3×FY 2024: -0.0×FY 2025: 1.8×
FY 2016 5y median 0.3× FY 2025
Interest Coverage -18.7×
FY 2016: -5.6×FY 2017: -8107×FY 2018: -3212×FY 2019: -35.2×FY 2020: -6.1×FY 2021: -30.0×FY 2022: -240×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -18.7×
FY 2016 5y median -18.7× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31